source
- Seaport Therapeutics goes public as obesity drug race heats up and FDA commissioner faces White House scrutinySeaport Therapeutics announced a successful initial public offering, with CEO Daphne Zohar discussing the company’s next steps on the latest Readout LOUD podcast. The episode also highlighted the…
- Health insurers grapple with profit cuts after a costly 2025, outlook for 2026 remains uncertainIn 2025, a wave of health insurers reduced or withdrew their profit forecasts after being hit by rising medical expenses. The cost pressures stemmed from higher drug prices, increased utilization…